Lifeward Partners with Ottobock Care to Expand ReWalk Exoskeleton Access
Event summary
- Lifeward Ltd. launched a six-month pilot program with Ottobock Care to expand access to the ReWalk® 7 Personal Exoskeleton in the U.S.
- Ottobock Care operates over 50 patient care clinics nationwide, providing clinical expertise and regional support for the exoskeleton.
- The partnership aims to increase awareness among rehabilitation centers and develop reimbursement expertise for broader distribution.
- Lifeward seeks a capital-efficient channel partner model to accelerate growth and improve commercial scalability.
The big picture
Lifeward's partnership with Ottobock Care aligns with its strategy to broaden ReWalk access through established patient care networks. The move reflects a broader trend in medical device companies leveraging specialized distributors to navigate complex reimbursement landscapes and expand market reach. Success hinges on Ottobock Care’s ability to integrate the exoskeleton into existing clinical workflows, potentially setting a precedent for similar collaborations in neurorehabilitation.
What we're watching
- Channel Strategy
- Whether Lifeward can sustain growth through partnerships without diluting brand control.
- Reimbursement Dynamics
- The pace at which Ottobock Care develops reimbursement expertise will determine scalability.
- Market Penetration
- How effectively the pilot increases awareness among rehabilitation centers and spinal cord injury clinics.
Related topics